BROWSE BY
0
Rhythm Pharmaceuticals, Inc. Banner Image

Rhythm Pharmaceuticals, Inc.

  • Ticker RYTM
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Rhythm Pharmaceuticals, Inc. Logo Image
  • 51-200 Employees
  • Based in Boston, Massachusetts
Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. Rhythm’s lead product candidate is setmelanotide, a first-in-class melanocortin-4 receptor (MC4R) agonist. Rhythm supports The Genetic Obesity Project (GeneticObesity.com) and the GO-ID Genotyping Study (GeneticObesityID.com).
Visit website
REPORT RATINGS
4.8 / 5.0 (129)

Rhythm Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 129 reviews.

Rhythm Pharmaceuticals, Inc.

Most Recent Annual Report

Rhythm Pharmaceuticals, Inc.
MOST RECENT 2023 Annual Report and Form 10K
View PDF View Form 10K (HTML)

Older/Archived Annual Reports

Show 3 older reports
x
Rhythm Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!